1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. UNITED THERAPEUTICS CORP
United Therapeutics Corp XNAS: UTHR

United Therapeutics Corp Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...

Read More
394.62 -5.90 (-1.47%)
New 52W High in past week
592.9K
XNAS Volume
High vol.+gain this week

XNAS 08 Sep, 2025 4:00 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The board meeting for United Therapeutics Corp is scheduled for today, for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
43.2 / 100
Momentum Score
Technically Moderately Bullish
61.5 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
448
1Yr Price target upside is 14%
12 analysts

26

S

4

W

0

O

2

T

SWOT Analysis

United Therapeutics Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..